Cystitis in male patients is a distinct clinical scenario with its own evidence-based management pathway. Male sex directly influences which antibiotics are appropriate, and how treatment duration and drug choice are determined.
This protocol is specific to male patients with cystitis. The applicable antibiotic options and their appropriate durations differ from protocols for other populations, with prostatic involvement being a key consideration in determining the preferred approach.
Antibiotic therapy is indicated. Several evidence-based options are available; the selection depends on local susceptibility data and patient-specific factors. Fluoroquinolones are among the agents that may be considered in male patients, subject to local susceptibility testing. The complete regimen — including agent choice, duration, and any age- or anatomy-related refinements — is detailed in the structured protocol.